Publications by authors named "Anne-Renee Hartman"

34Publications

Projected Reductions in Absolute Cancer-Related Deaths from Diagnosing Cancers Before Metastasis, 2006-2015.

Cancer Epidemiol Biomarkers Prev 2020 May 30;29(5):895-902. Epub 2020 Mar 30.

University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-19-1366DOI Listing
May 2020

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.

J Clin Oncol 2017 Apr 30;35(10):1086-1095. Epub 2017 Jan 30.

Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Hajime Uno, Chinedu I. Ukaegbu, Lauren K. Brais, Philip G. McNamara, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Dana-Farber Cancer Institute; Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Hajime Uno, Jason L. Hornick, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Harvard Medical School; Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Jason L. Hornick, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Brigham and Women's Hospital, Boston, MA; and Brian A. Allen, John Kidd, Nanda Singh, Anne-Renee Hartman, and Richard J. Wenstrup, Myriad Genetics, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.0012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455355PMC
April 2017

Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort.

Mod Pathol 2016 11 22;29(11):1381-1389. Epub 2016 Jul 22.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2016.135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541389PMC
November 2016

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

J Clin Oncol 2016 May 14;34(13):1460-8. Epub 2016 Mar 14.

Nadine Tung, Beth Israel Deaconess Medical Center; Nancy U. Lin, Eric P. Winer, and Judy E. Garber, Dana-Farber Cancer Institute; Nadine Tung, Nancy U. Lin, Eric P. Winer, and Judy E. Garber, Harvard Medical School, Boston, MA; and John Kidd, Brian A. Allen, Nanda Singh, Richard J. Wenstrup, and Anne-Renee Hartman, Myriad Genetic Laboratories, Inc., Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.0747DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872307PMC
May 2016

Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.

Gastroenterology 2015 Sep 14;149(3):604-13.e20. Epub 2015 May 14.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2015.05.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550537PMC
September 2015

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.

J Clin Oncol 2015 Jun 6;33(17):1902-9. Epub 2015 Apr 6.

Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.6660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451173PMC
June 2015

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.

J Clin Oncol 2015 Jun 6;33(17):1895-901. Epub 2015 Apr 6.

Melinda L. Telli, Kristin C. Jensen, Shaveta Vinayak, Allison W. Kurian, Jafi A. Lipson, Patrick J. Flaherty, Elizabeth A. Schackmann, Irene L. Wapnir, Robert W. Carlson, Pei-Jen Chang, and James M. Ford, Stanford University School of Medicine, Stanford; Bobbie Head, Marin Specialty Care, Greenbrae, CA; Kirsten Timms, Victor Abkevich, Julia E. Reid, and Anne-Renee Hartman, Myriad Genetics, Salt Lake City, UT; Joseph A. Sparano, Albert Einstein College of Medicine, New York, NY; Lori J. Goldstein, Fox Chase Cancer Center, Philadelphia, PA; Barbara Haley, University of Texas Southwestern Medical Center, Dallas, TX; Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS; and Judith Manola, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.0085DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451172PMC
June 2015

Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinoma.

J Thorac Oncol 2015 Jan;10(1):67-73

*Division of Thoracic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; †Myriad Genetics, Inc., Salt Lake City, UT; ‡Myriad Genetic Laboratories, Inc., Salt Lake City, UT, §Levine Cancer Institute, Charlotte, NC, ‖Istituto Europeo di Oncologia, Milan, Italy; ¶Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; #Royal Infirmary of Edinburgh, Edinburgh, Scotland; and **School of Medicine, University of St. Andrews, St. Andrews, Scotland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272230PMC
January 2015

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.

Cancer 2015 Jan 3;121(1):25-33. Epub 2014 Sep 3.

Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29010DOI Listing
January 2015

Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells.

BMC Pharmacol 2011 Jul 19;11. Epub 2011 Jul 19.

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Center for Clinical Sciences Research, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2210-11-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146825PMC
July 2011

Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage.

Breast J 2007 May-Jun;13(3):281-6

Department of Radiology, Division of Oncology, Stanford University School of Medicine, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2007.00422.xDOI Listing
July 2007

Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway.

Mol Cancer Ther 2006 Apr;5(4):952-61

Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-05-0493DOI Listing
April 2006

Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk.

Cancer Epidemiol Biomarkers Prev 2005 May;14(5):1082-9

Division of Oncology, Department of Medicine, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305-5820.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-04-0776DOI Listing
May 2005

The problems with risk selection; scientific and psychosocial aspects.

Recent Results Cancer Res 2005 ;166:125-44

Dana Farber Cancer Institute, 44 Binney Street, SM 203, Boston, MA 0211, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/3-540-26980-0_10DOI Listing
February 2005

Current comprehensive assessment and management of women at increased risk for breast cancer.

Am J Surg 2004 Mar;187(3):349-62

Department of Surgery, Mercy Health Center, Mercy Women's Center, 4300 McAuley Blvd., Oklahoma City, OK 73120, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2003.12.025DOI Listing
March 2004

Prophylactic oophorectomy and hormone replacement therapy: protection at what price?

J Clin Oncol 2004 Mar 23;22(6):978-80. Epub 2004 Feb 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.01.926DOI Listing
March 2004

BRCA1 and p53: compensatory roles in DNA repair.

J Mol Med (Berl) 2003 Nov 9;81(11):700-7. Epub 2003 Sep 9.

Department of Medicine, School of Medicine, Stanford University, 269 Campus Drive, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://jamesfordlab.stanford.edu/pdfs/ARH_JMF_2003.pdf
Web Search
http://link.springer.com/10.1007/s00109-003-0477-0
Publisher Site
http://dx.doi.org/10.1007/s00109-003-0477-0DOI Listing
November 2003

BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair.

Nat Genet 2002 Sep 26;32(1):180-4. Epub 2002 Aug 26.

Department of Internal Medicine (Oncology), Stanford University Medical Center, Stanford, California 94305-5151, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng953DOI Listing
September 2002